Table 2.
Cell Type | SPION Core-Coating (Name If Given) | SPION Diamete (nm) | SPION Incubation Concentration (μg/mL) | Incubation Period | Iron Content per Cell (pg) | Experiment Duration (Days) | Impact on Osteogenic Differentiation | Other Experiments |
---|---|---|---|---|---|---|---|---|
Rat BMSCs [88] | Iron oxide- citric acid | 96 | 50 | 72 h | 13 | 14 | Impaired | Reduced cell viability with increasing concentration. |
Rat ADSCs [88] | Iron oxide- citric acid | 96 | 50 | 72 h | 13 | 14 | Impaired | Reduced cell viability with increasing concentration. |
hMSCs [91] | Magnetite- amine (NH3+) | 6 | 50 | 72 h | 200 | 21 | Impaired | Improved cell proliferation. |
hMSCs [92] | Iron oxide- carboxydextran (Ferucarbotran) | 62 | 100 | 60 min | NI | 7 | Impaired | Cell mobilisation was promoted. |
hMSCs [95] | Iron oxide- silica | 4.5 | 50 | 4 days | 4 | 14 | Unaffected | Cell viability and proliferation was unimpacted. No changes in gene expression of VEGF or anti-inflammatory factors. No tissue damage or blood toxicity in-vivo after 7 weeks. |
hMSCs [88] | Magnetite- citric acid | 48 | 100 | 72 h | NI | 14 | Unaffected | Cell viability was unaffected. |
Canine ADSCs [89] | Magnetite | 10 | 50 | 12 h | 28 | 21 | Unaffected | Cell viability and proliferation were unimpacted. |
hMSCs [93] | Magnetite- PDA | 57 | 50 | 24 h | NI | 21 | Unaffected | Cell viability and proliferation were unaffected. |
hMSCs [90] | Iron oxide- citrate | 98 | 25 | 24 h | 70 | NI | Unaffected | No cytotoxicity was observed. |
hMSCs [90] | Iron oxide- dextran (Ferumoxide) | 157 | 500 | 24 h | 26 | NI | Unaffected | No cytotoxicity was observed. |
hMSCs [20] | Maghemite- PSC | 30 | 100 | 72 h | NI | 21 | Promoted | Cell viability was unimpacted. |
hMSCs [18] | Magnetite- silica | 55 | 100 | 24 h | NI | 14 | Promoted | Cell viability and proliferation were unaffected. |
hMSCs [28] | Maghemite- PSC | 30 | 100 | 48 h | 0.9 | 21 | Promoted | Cell viability was unimpacted. |
Magnetite—; Maghemite—. Core was referred to as “Iron oxide” if not mentioned in the study. Abbreviations: PDA—Polydopamine, PSC—polyglucose sorbitol carboxymethyl-ether.